
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
You remain concerned that he has a serious problem. Might he have one of the more common diagnoses in a 2-year-old who refuses to walk?






